Stem Cells and the FDA: California's Lobbying for Easier Approval Triggers Opposition
The $3 billion California stem cell agency came in for some sharp criticism last week in an opinion piece in the San Francisco Chronicle that was written by a UC Davis stem cell researcher who said the agency is engaged in politicking that "risks doing much more harm than good."
Paul Knoepfler, the scientist who also produces "The Niche" stem cell blog, …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.